KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Research & Development (2016 - 2026)

Idexx Laboratories has reported Research & Development over the past 17 years, most recently at $66.8 million for Q4 2025.

  • For Q4 2025, Research & Development rose 15.77% year-over-year to $66.8 million; the TTM value through Dec 2025 reached $251.2 million, up 14.29%, while the annual FY2025 figure was $251.2 million, 14.29% up from the prior year.
  • Research & Development for Q4 2025 was $66.8 million at Idexx Laboratories, up from $63.4 million in the prior quarter.
  • Over five years, Research & Development peaked at $123.2 million in Q2 2022 and troughed at $37.6 million in Q1 2021.
  • A 5-year average of $53.9 million and a median of $49.9 million in 2022 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: skyrocketed 226.87% in 2022 and later tumbled 62.26% in 2023.
  • Year by year, Research & Development stood at $45.3 million in 2021, then fell by 4.17% to $43.4 million in 2022, then grew by 19.33% to $51.8 million in 2023, then grew by 11.42% to $57.7 million in 2024, then grew by 15.77% to $66.8 million in 2025.
  • Business Quant data shows Research & Development for IDXX at $66.8 million in Q4 2025, $63.4 million in Q3 2025, and $61.9 million in Q2 2025.